Parabilis Medicines, Inc. (PBLS) ownership: insiders 23% · institutions 79% (13F 2026-06-30). Insider activity, 90 days: Insiders bought (0 sales, 6 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 28933371.00 | $791.91M | 23.7% | 2026-06-30 |
| FMR (Fidelity) | 10292735.00 | $281.71M | 8.4% | 2026-06-30 |
| ARCH Venture Management, LLC | 6412780.00 | $175.52M | 5.3% | 2026-06-30 |
| venBio Partners LLC | 5266697.00 | $144.15M | 4.3% | 2026-06-30 |
| Alphabet Inc. | 4919498.00 | $134.65M | 4.0% | 2026-06-30 |
| Nextech Invest Ltd. | 4663176.00 | $127.63M | 3.8% | 2026-06-30 |
| Cormorant Asset Management, LP | 4615612.00 | $126.33M | 3.8% | 2026-06-30 |
| Regeneron Pharmaceuticals, Inc. | 4166666.00 | $114.04M | 3.4% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-22 | |
| Buy | null | 2026-07-20 | |
| Buy | null | 2026-07-20 | |
| Buy | null | 2026-07-20 | |
| Buy | null | 2026-07-20 | |
| Buy | null | 2026-07-20 | |
| Buy | null | 2026-07-20 | |
| Buy | null | 2026-06-12 |
Back to PBLS overview · PBLS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.